The Effects of Malaria in Pregnancy on Neurocognitive Development in Children at 1 and 6 Years of Age in Benin: A Prospective Mother-Child Cohort

Amanda Garrison, Michael J Boivin, Nadine Fiévet, Roméo Zoumenou, Jules M Alao, Achille Massougbodji, Michel Cot, Florence Bodeau-Livinec, Amanda Garrison, Michael J Boivin, Nadine Fiévet, Roméo Zoumenou, Jules M Alao, Achille Massougbodji, Michel Cot, Florence Bodeau-Livinec

Abstract

Background: Malaria in pregnancy (MiP) contributes significantly to infant mortality rates in sub-Saharan Africa and has consequences on survivors, such as preterm birth and low birth weight. However, its impact on long-term neurocognitive development in children remains unknown.

Methods: Our prospective cohort included pregnant women and their live-born singletons from the Malaria in Pregnancy Preventive Alternative Drugs clinical trial. MiP was assessed using microscopy and real-time quantitative polymerase chain reaction (qPCR). Neurocognitive development in children was assessed using the Mullen Scales of Early Learning and the Kaufman Assessment Battery for Children, 2nd edition (KABC-II), at 1 and 6 years of age, respectively.

Results: Of 493 pregnant women, 196 (40%) were infected with malaria at least once: 121 (31%) with placental malaria diagnosed by qPCR. Multiple linear regression B-coefficients showed that impaired gross motor scores were associated with MiP at least once (-2.55; confidence interval [95% CI]: -5.15, 0.05), placental malaria by qPCR (-4.95; 95% CI: -7.65, -2.24), and high parasite density at delivery (-1.92; 95% CI: -3.86, 0.02) after adjustment. Malaria and high parasite density at the second antenatal care visit were associated with lower KABC-II Non-Verbal Index scores at 6 years (-2.57 [95% CI: -4.86, -0.28] and -1.91 [-3.51, -0.32]), respectively.

Conclusions: This prospective cohort study provides evidence that MiP, particularly late term, could have important negative consequences on child development at 1 and 6 years of age. Mechanisms behind this association must be further investigated and diagnostic methods in low-income countries should be strengthened to provide adequate treatment.

Clinical trials registration: NCT00811421.

Keywords: child development; malaria; neurocognition; pregnancy; sub-Saharan Africa.

© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America.

Figures

Figure 1.
Figure 1.
Population follow-up of women and children from pregnancy until 6 years of age. Abbreviations: APEC, Anemia in Pregnancy: Etiologies and Consequences; MiPPAD, Malaria in Pregnancy Preventive Alternative Drugs.
Figure 2.
Figure 2.
Linear regression B-coefficients and confidence intervals of association between MiP and child neurocognitive development at 1 year of age. White diamond, unadjusted B-coefficients and 95% bootstrapped confidence intervals. Black diamond, adjusted B-coefficients and 95% bootstrapped confidence intervals; controlling for maternal age and education, gravidity, prepregnancy BMI, family possession score, HOME score, and child sex and age at time of neurocognitive assessment. Abbreviations: ANV, antenatal visit; BMI, body mass index; HOME, Home Observation for Measurement of the Environment; MiP, malaria in pregnancy; qPCR, quantitative polymerase chain reaction.
Figure 3.
Figure 3.
Linear regression B-coefficients and confidence intervals of association between MiP and child neurocognitive development at 6 years of age. White diamond, unadjusted B-coefficients and 95% bootstrapped confidence intervals. Black diamond, adjusted B-coefficients and 95% bootstrapped confidence intervals; controlling for maternal age and education, gravidity, prepregnancy BMI, family possession score, HOME score, and child sex and age at time of neurocognitive assessment. Abbreviations: ANV, antenatal visit; BMI, body mass index; HOME, Home Observation for Measurement of the Environment; KABC-II, Kaufman Assessment Battery for Children, 2nd edition; MiP, malaria in pregnancy; qPCR, quantitative polymerase chain reaction.

References

    1. Desai M, ter Kuile FO, Nosten F, et al. . Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis 2007; 7:93-104.
    1. Bauserman M, Conroy AL, North K, Patterson J, Bose C, Meshnick S. An overview of malaria in pregnancy. Semin Perinatol 2019; 43:282-90.
    1. Schantz-Dunn J, Nour NM. Malaria and pregnancy: a global health perspective. Rev Obstet Gynecol 2009; 2:186-92.
    1. Guyatt HL, Snow RW. Impact of malaria during pregnancy on low birth weight in sub-Saharan Africa. Clin Microbiol Rev 2004; 17:760-9.
    1. Le Port A, Cottrell G, Martin-Prevel Y, Migot-Nabias F, Cot M, Garcia A. First malaria infections in a cohort of infants in Benin: biological, environmental and genetic determinants. Description of the study site, population methods and preliminary results. BMJ Open 2012; 2:e000342.
    1. McDonald CR, Cahill LS, Ho KT, et al. . Experimental malaria in pregnancy induces neurocognitive injury in uninfected offspring via a C5a-C5a receptor dependent pathway. PLoS Pathog 2015; 11:e1005140.
    1. Weckman AM, Ngai M, Wright J, McDonald CR, Kain KC. The impact of infection in pregnancy on placental vascular development and adverse birth outcomes. Front Microbiol 2019; 10:1924.
    1. González R, Mombo-Ngoma G, Ouédraogo S, et al. . Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: a multicentre randomized controlled trial. PLoS Med 2014; 11:e1001733.
    1. Bodeau-Livinec F, Glorennec P, Cot M, et al. . Elevated blood lead levels in infants and mothers in Benin and potential sources of exposure. Int J Environ Res Public Health 2016; 13:316.
    1. Ouédraogo S, Accrombessi M, Diallo I, et al. . Placental impression smears is a good indicator of placental malaria in sub-Saharan Africa. Pan Afr Med J 2019; 34:30.
    1. Swysen C, Vekemans J, Bruls M, et al. ; Clinical Trials Partnership Committee. Development of standardized laboratory methods and quality processes for a phase III study of the RTS, S/AS01 candidate malaria vaccine. Malar J 2011; 10:223.
    1. Ndam NT, Mbuba E, González R, et al. . Resisting and tolerating P. falciparum in pregnancy under different malaria transmission intensities. BMC Med 2017; 15:130.
    1. Koura KG, Boivin MJ, Davidson LL, et al. . Usefulness of child development assessments for low-resource settings in francophone Africa. J Dev Behav Pediatr 2013; 34:486-93.
    1. Bodeau-Livinec F, Davidson LL, Zoumenou R, Massougbodji A, Cot M, Boivin MJ. Neurocognitive testing in West African children 3-6 years of age: challenges and implications for data analyses. Brain Res Bull 2018; 145:129-35.
    1. Boivin MJ, Zoumenou R, Sikorskii A, et al. . Neurodevelopmental assessment at one year of age predicts neuropsychological performance at six years in a cohort of West African Children. Child Neuropsychol 2021:548-71.
    1. Mireku MO, Boivin MJ, Davidson LL, et al. . Impact of helminth infection during pregnancy on cognitive and motor functions of one-year-old children. PLoS Negl Trop Dis 2015; 9:e0003463.
    1. Elphinstone RE, Weckman AM, McDonald CR, et al. . Early malaria infection, dysregulation of angiogenesis, metabolism and inflammation across pregnancy, and risk of preterm birth in Malawi: a cohort study. PLoS Med 2019; 16:e1002914.
    1. Sania A, Sudfeld CR, Danaei G, et al. . Early life risk factors of motor, cognitive and language development: a pooled analysis of studies from low/middle-income countries. BMJ Open 2019; 9:e026449.
    1. Cottrell G, Moussiliou A, Luty AJ, et al. . Submicroscopic Plasmodium falciparum infections are associated with maternal anemia, premature births, and low birth weight. Clin Infect Dis 2015; 60:1481-8.
    1. Boivin MJ, Bangirana P, Byarugaba J, et al. . Cognitive impairment after cerebral malaria in children: a prospective study. Pediatrics 2007; 119:e360-6.
    1. Accrombessi M, Yovo E, Fievet N, et al. . Effects of malaria in the first trimester of pregnancy on poor maternal and birth outcomes in Benin. Clin Infect Dis 2019; 69:1385-93.
    1. Kalilani-Phiri L, Thesing PC, Nyirenda OM, et al. . Timing of malaria infection during pregnancy has characteristic maternal, infant and placental outcomes. PLoS One 2013; 8:e74643.
    1. Mahande AM, Mahande MJ. Prevalence of parasitic infections and associations with pregnancy complications and outcomes in northern Tanzania: a registry-based cross-sectional study. BMC Infect Dis 2016; 16:78.
    1. World Health Organization. WHO policy brief for the implementation of intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP) [Internet], 2013. Geneva, Switzerland: World Health Organization. Available at: . Accessed 3 December 2021.
    1. Al-Haddad BJS, Jacobsson B, Chabra S, et al. . Long-term risk of neuropsychiatric disease after exposure to infection in utero. JAMA Psychiatry 2019; 76:594-602.
    1. Canetta SE, Bao Y, Co MD, et al. . Serological documentation of maternal influenza exposure and bipolar disorder in adult offspring. Am J Psychiatry 2014; 171:557-63.
    1. Knuesel I, Chicha L, Britschgi M, et al. . Maternal immune activation and abnormal brain development across CNS disorders. Nat Rev Neurol 2014; 10:643-60.
    1. Huynh BT, Fievet N, Gbaguidi G, et al. . Influence of the timing of malaria infection during pregnancy on birth weight and on maternal anemia in Benin. Am J Trop Med Hyg 2011; 85:214-20.
    1. Uneke CJ. Impact of placental Plasmodium falciparum malaria on pregnancy and perinatal outcome in sub-Saharan Africa: II: effects of placental malaria on perinatal outcome; malaria and HIV. Yale J Biol Med 2007; 80:95-103.
    1. Bigira V, Kapisi J, Clark TD, et al. . Protective efficacy and safety of three antimalarial regimens for the prevention of malaria in young Ugandan children: a randomized controlled trial. PLoS Med 2014; 11:e1001689.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir